GlassScriptPhysician profile
Jenny Ye
NPI 1407430184
$677.44
in general payments reported to CMS, 2019-2025
13 companies · $638 in 2025
The $638 reported for 2025 was more than what 90% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.35 · 2023: $18.43 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $152.05 | 2025 | |
| Astellas Pharma US INC | $98.92 | 2025 | Veozah |
| Millicent US INC | $97.04 | 2025 | Femlyv, Intrarosa |
| Exeltis, USA INC. | $77.34 | 2025 | Slynd |
| Janssen Biotech, INC. | $65.48 | 2025 | Erleada |
| Evofem Biosciences, INC. | $45.23 | 2025 | Solosec, Phexx, Phexxi |
| Bayer Healthcare Pharmaceuticals INC. | $25.32 | 2025 | |
| Hologic Sales and Service, LLC | $22.45 | 2025 | Novasure |
| Mallinckrodt Hospital Products INC. | $21.35 | 2021 | |
| Antares Pharma, INC. | $21.03 | 2025 | Xyosted |
| Glaxosmithkline, LLC. | $18.43 | 2023 | Bexsero |
| Tolmar, INC. | $17.04 | 2025 | Jatenzo |
| Sumitomo Pharma America, INC. | $15.76 | 2025 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Ye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.